Drawing for ATERONON

USPTO serial 79049889

ATERONON

Reviewed by CopyMark Law Group

Reg. 3679878Status 404
Filing date
Status date
Registration date
Sep 8, 2009
Examiner
HABEEB, MYRIAH A
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ATERONON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

Susan Upton Douglass Fross Zelnick Lehrman & Zissu, P.C.4 TIMES SQUARE, 17TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005dietary and nutritional supplements for medical use; dietary food supplements for medical use; dietary food supplements and substances for medical use, namely, formulations comprised of carotenoids for preventing and treating chronic inflammation, heart failure, metabolic syndromes, [ diabetes, ] hypertension, [ hypoxia, ] atherosclerosis and the clinical complications of atherosclerosis, for inhibiting lipid oxidation, and for use as anti-oxidants; chemical substances for therapeutic use, namely, antioxidants which can inhibit oxidative inflammatory damage for preventing and treating chronic inflammation, heart failure, metabolic syndromes, [ diabetes, ] hypertension, [ hypoxia, ] atherosclerosis and the clinical complications of atherosclerosis, for inhibiting lipid oxidation, and for use as anti-oxidants; pharmaceutical preparations comprised of carotenoids for preventing and treating chronic inflammation, heart failure, metabolic syndromes, [ iabetes, ] hypertension, [ hypoxia, ] atherosclerosis and the clinical complications of atherosclerosis, for inhibiting lipid oxidation, and for use as anti-oxidantsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 17, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 17, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
May 23, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 28, 2015NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 28, 2015C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Apr 28, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 15, 2015ES75TEAS SECTION 71 & 15 RECEIVED—
May 3, 2013CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 27, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 11, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 11, 2010FIMPFINAL DISPOSITION PROCESSED—
Dec 8, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2009OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 13, 2009OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 13, 2009OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 23, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2009NPUBNOTICE OF PUBLICATION—
May 18, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 18, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 28, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 28, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2009ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 24, 2009EXPIEX PARTE APPEAL-INSTITUTED—
Apr 24, 2009JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Apr 24, 2009EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Nov 13, 2008CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 12, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 20, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 20, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2008ALIEASSIGNED TO LIE—
Oct 1, 2008MAILPAPER RECEIVED—
May 3, 2008RFNTREFUSAL PROCESSED BY IB—
Apr 2, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 2, 2008RFRRREFUSAL PROCESSED BY MPU—
Apr 1, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 31, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2008DOCKASSIGNED TO EXAMINER—
Mar 14, 2008NWAPNEW APPLICATION ENTERED—
Mar 13, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance